• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 101967-950
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Rash (2033); Anaphylactoid (2218); Skin Inflammation/ Irritation (4545)
Event Date 10/31/2023
Event Type  Injury  
Manufacturer Narrative
A review of the device's manufacturing records revealed that the sensor lot met all requirements including sterilization requirements for release.The sensor is inserted by making a small incision and placing it under skin and potential for developing skin irritation/swelling/pain/ inflammation/infection around the insertion site is a known anticipated adverse event.Patient reported that they get allergies every time a new sensor gets inserted, happening since the first insertion in 2019.The current sensor was patient's 10th sensor.The hcp told patient that it could be either due to lidocaine or insertion tools, sensor or adhesives (tegaderm and steri-strips).The hcp prescribed antihistamine and cortisone cream for prevention.The patient is still using the system with up to date glucose information.The patient was recommended to contact hcp for any medical assistance.This incident does not require any further investigation.
 
Event Description
Senseonics was made aware of an incident where patient reported allergic reaction every time a new sensor gets inserted, happening since 2019.The most recent sensor was inserted on (b)(6) 2023.The patient reported that they get allergic to everything, but nothing specific information was provided.The hcp said it could be related to lidocaine, tools, sensor or adhesives (tegaderm and steri-strips).Symptoms include redness and rash that spreads from her arm to her throat and disappears after three days.The hcp prescribed antihistamine tablets and cortisone cream for prevention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE SENSOR
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18361379
MDR Text Key330930945
Report Number3009862700-2023-00830
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 12/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/08/2023
Device Model Number101967-950
Device Catalogue NumberFG-4500-50-302
Device Lot NumberWP09149
Was Device Available for Evaluation? No
Date Manufacturer Received11/24/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/10/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-